It has been reported previously that antagonists and inverse agonists of histamine H3 receptors are also capable of reducing the level of triglycerides in plasma [7], which is important since lipid abnormalities associated with obesity might highly increase the risk of developing the type II diabetes and cardiovascular system diseases. The gene discussed is HRH3; the disease is obesity disorder.